Get the Daily Brief
Latest Biotech News
Biological Insights Into Parkinson’s Disease Emerge from Diverse Studies
A series of groundbreaking investigations are deepening the understanding of Parkinson’s disease pathology and treatment. Research includes the modulation of brain networks through different...
Gut Bacteria Bioaccumulate Toxic PFAS Chemicals Affecting Human Health
Researchers have discovered that human gut bacteria can bioaccumulate per- and polyfluoroalkyl substances (PFAS), widely known as 'forever chemicals' that persist in the human body and environment...
AbbVie Acquires Capstan Therapeutics: $2.1 Billion Bet on In Vivo CAR-T
AbbVie has agreed to acquire Capstan Therapeutics for up to $2.1 billion, aiming to expand its footprint in the emerging in vivo CAR-T therapy market. Capstan’s lipid nanoparticle-based mRNA...
Mid-Stage Success Spurs Beckley Psytech and Atai Merger in Psychedelic Depression Therapy
Beckley Psytech’s intranasal psychedelic treatment for treatment-resistant depression has met key endpoints in a Phase 2b trial, prompting a merger with Atai Life Sciences. The compound,...
Moderna’s mRNA Flu Vaccine Outperforms Competitors, Sets Stage for FDA Submission
Moderna announced strong Phase 3 results for its mRNA-based influenza vaccine, demonstrating a 26.6% relative efficacy over an approved standard-dose seasonal flu shot in adults aged 50 and older...
Chemotherapy-Induced Genetic Mutations Illuminate Safer Treatment Pathways
A collaborative study from the Wellcome Sanger Institute and University of Cambridge has delineated distinct mutational signatures in normal blood cells associated with various chemotherapy...
Novel AI Platforms and Machine Learning Models Enhance Cancer Prognosis and Drug Discovery
Innovations in artificial intelligence are transforming oncology diagnostics and drug discovery. Imagene AI secured $23 million in Series B funding to advance multimodal digital pathology models...
Breakthrough in Glioblastoma Targeting Molecular Motors Improves Treatment Response
Researchers at the Herbert Wertheim UF Scripps Institute unveiled MT-125, a novel drug targeting non-muscle myosin IIA and IIB, that sensitizes glioblastoma tumors to radiation and kinase...
Advances in Parkinson’s Disease Diagnostics and Therapeutics Driven by Machine Learning and Brain Stimulation
A series of studies highlight pivotal shifts in Parkinson’s disease research and treatment. Machine learning models have been developed to track levodopa’s acute effects via digital speech...
Emerging Immunotherapies and Molecular Targets in Cancer Treatment
Recent breakthroughs showcase innovative immunotherapy approaches and target identifications in oncology. ARX788 combined with pyrotinib outperformed standard regimens in HER2+ breast cancer,...
Regulatory and Market Dynamics Impacting Biotech Sector Financing and Operations
The biotech industry faces significant operational challenges as Apple Tree Partners engages in litigation with its main investor, citing funding failures threatening portfolio startups' survival....
AbbVie Buys In Vivo CAR-T Biotech for $2.1 Billion
AbbVie has announced the acquisition of Capstan Therapeutics for up to $2.1 billion in cash, marking a significant expansion into in vivo CAR-T therapies. Capstan’s lead candidate, CPTX2309, a...
Psychedelic Drug Shows Promise, Spurs Biotech Merger Plans
Mid-stage trial data from Beckley Psytech’s intranasal psychedelic compound BPL-003 demonstrated significant symptom reduction in treatment-resistant depression, outperforming a low-dose...
New AI Advances Precision Oncology and Drug Discovery
Innovations in artificial intelligence are driving breakthroughs in cancer diagnostics, drug discovery, and clinical trial optimization. Imagene AI secured $23 million in Series B funding to...
Moderna’s mRNA Flu Vaccine Outperforms Licensed Comparator, FDA Talks Loom
Moderna announced positive Phase 3 results for its mRNA-1010 seasonal influenza vaccine, demonstrating a 26.6% relative vaccine efficacy over a standard-dose marketed influenza shot in adults aged...
New Insights into Chemotherapy’s Genetic Impact on Healthy Blood Cells
A comprehensive study led by the Wellcome Sanger Institute and University of Cambridge systematically examined the somatic genetic effects of chemotherapy on normal blood cells. Using whole-genome...
Breakthrough in Targeting Hard-to-Treat Breast Cancers
Researchers have highlighted the role of circular RNA circLIMK1-005 in promoting lung adenocarcinoma progression via interaction with the RPA1-CDK4 pathway, offering a promising molecular target....
Gut Microbiota and Metabolites Linked to Neurological Disorders
Groundbreaking studies have unveiled novel connections between the gut microbiome and neurological diseases. One investigation reveals that alterations in gut-derived metabolites are associated...
Biotech Venture Funding and Market Movements Shape Industry Landscape
Catalio Capital Management has closed its $400 million Nexus Fund IV to invest in novel healthcare innovations amid a challenging buyer’s market in biotech. The fund supports new company launches...
Precision Medicine Advances with Machine Learning and Genomics Integration
Significant progress is being made in leveraging machine learning and genomic data to improve disease prediction and treatment personalization. Novel algorithms predict breast cancer incidence...